By Mike Sunnucks | Rose Law Group Reporter
Tempe-based Applied Microarrays Inc. — which manufactures DNA and protein microsensors and arrays used biotechnology, medical and biochemistry applications — is being acquired by Schott Minifab.
Australia-based Schott makes diagnostics and life science products. It is a subsidiary of German-based Schott AG.
The merger will expand Schott Minifabs “biosensor printing capabilities”, according to a release announcing the deal.
“We pride ourselves on being an end-to-end partner for the global diagnostics industry. Our expansive offering allows us to provide an integrated single-source collection of value-intensive services and products. With the added bioscience knowledge of AMI, we become an even stronger partner, enhancing our capability in surface modification, functionalization and deposition for both glass and polymer products,” said Greg Wolters, head of Schott Minifab.
AMI also has plans to move to a larger facility in Phoenix, the companies said Tuesday.
“We are joining Schott at a time when the market continues to steer toward point-of-care diagnostics,” said Alastair Malcolm, CEO of AMI. “Our joint knowledge and technical capability allows us to offer a more holistic approach while shortening the time to market for customers.”